News
The most dramatic symptoms of GCA (for example, visual loss) result directly from the inflammation of the large- and medium-sized cranial vessels. Other symptoms appear nonspecific and are related ...
Giant cell arteritis, or GCA, is a condition where arteries in the head and neck become inflamed. It is called ‘giant cell’ because abnormally large cells accumulate in the artery walls.
(RTTNews) - AbbVie (ABBV) Tuesday said the U.S. Food and Drug Administration (FDA) has approved Rinvoq for the treatment of adults with giant cell arteritis (GCA). GCA is an autoimmune disease ...
Hosted on MSN1mon
AbbVie's Rinvoq Gets EU Nod for 8th Indication Giant Cell ArteritisIn the study, 46% of the GCA patients treated with Rinvoq plus 26-week steroid taper regimen achieved the primary endpoint of sustained remission (absence of GCA signs and symptoms) from week 12 ...
1 This comes after the European Commission recently granted marketing authorization of RINVOQ for the treatment of GCA in adult patients. The approvals are supported by results of the pivotal ...
The long-term therapy and surveillance of patients with GCA is important. The side effects of long-term steroid therapy are protean and must be addressed. All patients need adequate calcium and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results